Anti-NKG2D single domain-based antibodies for the modulation of anti-tumor immune response
Author:
Affiliation:
1. Cancer Research Center of Marseille, INSERM, CNRS, Aix Marseille Université, Institut Paoli - Calmettes, Marseille, France
2. Sanofi Biologics Research, Vitry-sur-Seine, France
3. Sanofi Oncology, Vitry-sur-Seine, France
Funder
INSERM and CNRS
Publisher
Informa UK Limited
Subject
Oncology,Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2020.1854529
Reference64 articles.
1. Immunomodulation in cancer
2. The immune contexture in cancer prognosis and treatment
3. Elements of cancer immunity and the cancer–immune set point
4. Combination cancer immunotherapy and new immunomodulatory targets
5. The blockade of immune checkpoints in cancer immunotherapy
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy;Pharmaceutics;2024-08-29
2. Bispecific killer cell engagers employing species cross-reactive NKG2D binders redirect human and murine lymphocytes to ErbB2/HER2-positive malignancies;Frontiers in Immunology;2024-08-29
3. The basic biology of NK cells and its application in tumor immunotherapy;Frontiers in Immunology;2024-08-16
4. NKG2D-bispecific enhances NK and CD8+ T cell antitumor immunity;Cancer Immunology, Immunotherapy;2024-08-08
5. Contemporary Approaches to Immunotherapy of Solid Tumors;Cancers;2024-06-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3